Browse EV MemProt Atlas
Supporting publications (n)

Number of publications supporting the inclusion of this protein in EV MemProt Atlas.

EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
UniProt IDProtein namesProtein classificationTransmembrane countRelated DiseasesMediation categoriesDownload
CNR2P34972Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins7Clinical-translation mediationImmune mediationReceptor-signaling mediation20.25
CY24BP04839NADPH oxidase 2 (EC 1.6.3.-) (CGD91-phox) (Cytochrome b(558) subunit beta) (Cytochrome b558 subunit beta) (Cytochrome b-245 heavy chain) (Heme-binding membrane glycoprotein gp91phox) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)Disease related genesHuman disease related genesPotential drug targets6Fusion and delivery mediationImmune mediationMetabolism mediation20.25
EFNA5P52803Ephrin-A5 (AL-1) (EPH-related receptor tyrosine kinase ligand 7) (LERK-7)Cancer-related genesPredicted membrane proteinsRAS pathway related proteinsAdhesion and uptake mediationFusion and delivery mediationMetabolism mediation20.25
EMP2P54851Epithelial membrane protein 2 (EMP-2) (Protein XMP)Disease related genesHuman disease related genesPredicted membrane proteins4Adhesion and uptake mediationFusion and delivery mediationImmune mediation20.25
EPHB4P54760Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11)Cancer-related genesDisease related genesEnzymes1Brain cancerCystic/dysplastic kidney diseaseLung cancerClinical-translation mediationReceptor-signaling mediation20.25
GTR9Q9NRM0Solute carrier family 2, facilitated glucose transporter member 9 (Glucose transporter type 9) (GLUT-9) (Urate transporter)Disease related genesHuman disease related genesMetabolic proteins12Clinical-translation mediationFusion and delivery mediation20.25
INAR1P17181Interferon alpha/beta receptor 1 (IFN-R-1) (IFN-alpha/beta receptor 1) (Cytokine receptor class-II member 1) (Cytokine receptor family 2 member 1) (CRF2-1) (Type I interferon receptor 1)Cancer-related genesDisease related genesFDA approved drug targets1Hepatitis virus infectionOvarian cancerClinical-translation mediationFusion and delivery mediationImmune mediation20.25
LMBD2Q68DH5G-protein coupled receptor-associated protein LMBRD2 (LMBR1 domain-containing protein 2)Disease related genesPotential drug targetsPredicted membrane proteins9Receptor-signaling mediation20.25
NLGNXQ8N0W4Neuroligin-4, X-linked (Neuroligin X) (HNLX)Disease related genesHuman disease related genesPotential drug targets1Fusion and delivery mediation20.25
NOTC1P46531Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]Cancer-related genesDisease related genesHuman disease related genes1LymphomaMature T-cell lymphomaSolid tumour/cancerAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.25
PCD19Q8TAB3Protocadherin-19Disease related genesHuman disease related genesPredicted intracellular proteins1Adhesion and uptake mediation20.25
S12A6Q9UHW9Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3)Disease related genesHuman disease related genesMetabolic proteins12Clinical-translation mediationFusion and delivery mediationMetabolism mediation20.25
S19A2O60779Thiamine transporter 1 (ThTr-1) (ThTr1) (Solute carrier family 19 member 2) (Thiamine carrier 1) (TC1)Disease related genesHuman disease related genesMetabolic proteins12Fusion and delivery mediationMetabolism mediation20.25
S1PR2O95136Sphingosine 1-phosphate receptor 2 (S1P receptor 2) (S1P2) (Endothelial differentiation G-protein coupled receptor 5) (Sphingosine 1-phosphate receptor Edg-5) (S1P receptor Edg-5)Disease related genesG-protein coupled receptorsHuman disease related genes7Ulcerative colitisClinical-translation mediationReceptor-signaling mediation20.25
SGCBQ16585Beta-sarcoglycan (Beta-SG) (43 kDa dystrophin-associated glycoprotein) (43DAG) (A3b)Disease related genesHuman disease related genesPredicted membrane proteins1Muscular dystrophyClinical-translation mediationFusion and delivery mediationMetabolism mediation20.25
SL9A7Q96T83Sodium/hydrogen exchanger 7 (Na(+)/H(+) exchanger 7) (NHE-7) (Solute carrier family 9 member 7)Disease related genesHuman disease related genesMetabolic proteins14Clinical-translation mediationFusion and delivery mediation20.25
T106BQ9NUM4Transmembrane protein 106BDisease related genesHuman disease related genesPotential drug targets1Fusion and delivery mediation20.25
TM63CQ9P1W3Osmosensitive cation channel TMEM63C (Calcium permeable stress-gated cation channel 1) (Transmembrane protein 63C) (hTMEM63C)Disease related genesHuman disease related genesPotential drug targets11Other mediation20.25
AGTR1P30556Type-1 angiotensin II receptor (AT1AR) (AT1BR) (Angiotensin II type-1 receptor) (AT1 receptor)Disease related genesFDA approved drug targetsG-protein coupled receptors7Alzheimer diseaseArteries/arterioles disorderEssential hypertensionClinical-translation mediationFusion and delivery mediationImmune mediation10.25
ANO5Q75V66Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E)Disease related genesHuman disease related genesPotential drug targets8Clinical-translation mediationFusion and delivery mediationImmune mediation10.25
ANPRCP17342Atrial natriuretic peptide receptor 3 (Atrial natriuretic peptide clearance receptor) (Atrial natriuretic peptide receptor type C) (ANP-C) (ANPR-C) (NPR-C)Disease related genesPredicted intracellular proteinsPredicted membrane proteins1Heart failureClinical-translation mediationImmune mediationMetabolism mediation10.25
AT1A3P13637Sodium/potassium-transporting ATPase subunit alpha-3 (Na(+)/K(+) ATPase alpha-3 subunit) (EC 7.2.2.13) (Na(+)/K(+) ATPase alpha(III) subunit) (Sodium pump subunit alpha-3)Disease related genesEnzymesHuman disease related genes10Clinical-translation mediationFusion and delivery mediation10.25
AVR2BQ13705Activin receptor type-2B (EC 2.7.11.30) (Activin receptor type IIB) (ACTR-IIB)Cancer-related genesDisease related genesEnzymes1Nervous system paraneoplastic/autoimmune disorderClinical-translation mediationFusion and delivery mediationImmune mediation10.25
BST1Q10588ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 (EC 3.2.2.6) (ADP-ribosyl cyclase 2) (Bone marrow stromal cell antigen 1) (BST-1) (Cyclic ADP-ribose hydrolase 2) (cADPR hydrolase 2) (CD antigen CD157)CD markersEnzymesFDA approved drug targetsAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation10.25
CA2D1P54289Voltage-dependent calcium channel subunit alpha-2/delta-1 (Voltage-gated calcium channel subunit alpha-2/delta-1) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-1; Voltage-dependent calcium channel subunit delta-1]FDA approved drug targetsPlasma proteinsPredicted intracellular proteins1Anxiety disorderCardiovascular diseaseChronic obstructive pulmonary diseaseClinical-translation mediationFusion and delivery mediation10.25

701-725 of 792 proteins

Page